Precision Cardiac Amyloid

Diagnostics and imaging · by InVision Medical Technology

AI screening for cardiac amyloidosis, a rare, underdiagnosed, and now-treatable disease, from routine transthoracic echocardiography.

What it does

AI screening for cardiac amyloidosis, a rare, underdiagnosed, and now-treatable disease, from routine transthoracic echocardiography. Integrates information across apical-4-chamber and parasternal-long-axis view videos to assess amyloid-associated features holistically. Developed with support from Alexion, AstraZeneca Rare Disease.

  • Automated echocardiographic LVEF measurement
  • AI screening for cardiac amyloidosis
  • Opportunistic liver disease screening from echocardiography
  • Automated structured echocardiographic report generation
  • Multi-valve disease detection (mitral, tricuspid, aortic)
  • Automatic DICOM deidentification for research and data sharing
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Health systems, Cardiovascular service lines, Echo labs, Data teams building research or AI training datasets
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

InVision Medical Technology doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by InVision Medical Technology. Ask for audit reports before you buy.

  • SOC 2Compliant
  • ISO 9001Compliant
  • HIPAACompliant
  • FDA 510(k) Clearance — Precision LVEFCompliant
  • FDA 510(k) Clearance — Precision Cardiac AmyloidCompliant
  • FDA Breakthrough Device Designation — Precision Cardiac AmyloidCompliant
  • FDA Breakthrough Device Designation — Precision CirrhosisCompliant
  • FDA Total Product Lifecycle Advisory Program (TAP) — Precision Cardiac AmyloidCompliant
  • CPT Category III code 0932T (effective January 1, 2025) — Precision Cardiac AmyloidCompliant
  • DICOM Part 15 compliance — Automatic DICOM DeidentificationCompliant
  • Session-only cookies (no persistent cookies)
  • Commercially reasonable physical, managerial, and technical safeguards
  • Security breach notification to affected users
  • Third-party processors required to use reasonable confidentiality measures and comply with Privacy Policy

Reviews

No reviews yet

Reviews come from people who use Precision Cardiac Amyloid at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim Precision Cardiac Amyloid